FDA, CLINUVEL to Discuss SCENESSE® at Pre-NDA Meeting
Oct 13, 2016 11:01 am UTC| Business
MELBOURNE, Australia and NEW YORK, Oct. 13, 2016 -- CLINUVEL PHARMACEUTICALS LTD (ASX:CUV) (OTC:CLVLY) (XETRA:UR9)today announced that it will meet with the US Food and Drug Administration (FDA) on 7 November to...
Pluristem CEO Zami Aberman Re-Elected to Alliance for Regenerative Medicine’s Board of Directors
Oct 13, 2016 11:01 am UTC| Business
HAIFA, Israel, Oct. 13, 2016 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced its Chairman and CEO, Zami Aberman, has been re-elected...
Aptose Provides Update on FDA Clinical Hold of APTO-253
Oct 13, 2016 11:01 am UTC| Business
SAN DIEGO and TORONTO, Oct. 13, 2016 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer,...
RedHill Biopharma to Present at the BIO Investor Forum 2016
Oct 13, 2016 11:00 am UTC| Business
TEL-AVIV, Israel, Oct. 13, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late...
Heat Biologics Remains on Track to Achieve Multiple Topline Data Readouts this Quarter
Oct 13, 2016 11:00 am UTC| Business
DURHAM, N.C., Oct. 13, 2016 -- Heat Biologics, Inc. (Nasdaq:HTBX), an immuno-oncology company developing novel therapies that activate a patient’s immune system against cancer, announced that it continues to remain on...
The Bon-Ton Stores, Inc. Expands Customer Loyalty Program with Launch of LoveStyle Rewards
Oct 13, 2016 11:00 am UTC| Business
MILWAUKEE, Oct. 13, 2016 -- The Bon-Ton Stores, Inc. (NASDAQ:BONT), which operates Bon-Ton, Boston Store, Bergner’s, Carson’s, Elder-Beerman, Herberger’s and Younkers stores, announced that it has expanded its customer...
Tonix Pharmaceuticals to Present at Dawson James Securities 2016 Small Cap Growth Stock Conference
Oct 13, 2016 11:00 am UTC| Business
NEW YORK, Oct. 13, 2016 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), which is developing a next-generation treatment for posttraumatic stress disorder (PTSD), announced today that it will present at the...